Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
about
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control studyThree decades of beta-lactamase inhibitorsKlebsiella pneumoniae: Going on the Offense with a Strong DefenseCarbapenemsGenetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in ThailandClinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive Analysis.CTX-M Enzymes: Origin and Diffusion.Clinical microbiology costs for methods of active surveillance for Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.Characteristics of carbapenemase-producing Klebsiella pneumoniae as a cause of neonatal infection in Shandong, ChinaFirst identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolatesRapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assayComparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae.Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.Membrane efflux and influx modulate both multidrug resistance and virulence of Klebsiella pneumoniae in a Caenorhabditis elegans model.Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital systemEvaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.Isolation of Enterobacter aerogenes carrying blaTEM-1 and blaKPC-3 genes recovered from a hospital Intensive Care Unit.Phylogenetic distribution and prevalence of genes encoding class I Integrons and CTX-M-15 extended-spectrum β-lactamases in Escherichia coli isolates from healthy humans in Chandigarh, IndiaActivity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiologyIn vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniaeSingle or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenemsThe spoIIE homolog of Epulopiscium sp. type B is expressed early in intracellular offspring development.Emergence of carbapenem resistance due to the novel insertion sequence ISPa8 in Pseudomonas aeruginosaSusceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolatesComparative evaluation of combined-disk tests using different boronic acid compounds for detection of klebsiella pneumoniae carbapenemase-producing enterobacteriaceae clinical isolates.The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight.Overexpression of an outer membrane protein associated with decreased susceptibility to carbapenems in Proteus mirabilisCarbapenem-nonsusceptible Enterobacteriaceae in TaiwanOutbreak of multidrug resistant NDM-1-producing Klebsiella pneumoniae from a neonatal unit in Shandong Province, China.Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.Enterobacter aerogenes and Enterobacter cloacae; versatile bacterial pathogens confronting antibiotic treatment.Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospitalKPC-2-producing Klebsiella pneumoniae in a hospital in the Midwest region of Brazil
P2860
Q21134706-EE3E477E-20BF-42A1-97F3-C240C1400BD1Q24646623-2C34B1E0-A041-4FB1-98D1-0DE5B5C19727Q26745802-7AA45CC7-88B9-45AB-87DE-B5B712222564Q28286055-3F1F2B39-04AE-4E06-9422-AAF0D6038A51Q28548463-FC4B60CF-3000-461E-8A42-1DF59B051128Q30234956-C893D3BE-45C8-407B-8753-7E563508A260Q30379480-F38F1A10-F1E7-40AD-A847-BCF4459FEF3AQ30415141-A12D9D1D-EB17-4119-AD90-3C20C96367BAQ30457566-0ABCC4DF-7928-4287-93AA-B37DB61769C9Q33597897-D34F931E-E6A3-40FB-AD85-C73457749453Q33642638-B7C854D6-A600-476D-A3E6-593033140413Q33960560-5429DA94-BD3B-490A-9978-7AAB198D878EQ34046522-25D8DBFD-3ABA-46F4-85F7-62BC720D3B0CQ34109281-53F63EDB-75B2-4313-892E-3ECD940E8185Q34151100-B484D7E4-DA6D-48AF-8B79-34791813403EQ34151206-A5B52DB7-D17C-4F24-A7D1-945CAA49683FQ34183819-DC9AA600-37AA-4601-B700-FB6F7FF03C2EQ34433108-B64FAE9F-0476-42B5-8FA8-6802BB4A98DDQ34519404-3389ADBB-5BCC-483F-B5A0-2E06E4A43800Q34542111-2AA1CD5C-841D-4017-AF92-1EFFD4A42B87Q34625178-8D666822-8A29-4FFB-8A99-78017FBE02FFQ34822378-598F53A0-3C6A-4085-A64E-EE9C257F754DQ35004824-8DB8635E-9D27-48AA-8097-023AF461357BQ35050528-41320C05-58DA-43D7-A86A-975E75E6C62CQ35096093-8761D8FC-632D-4D98-A58C-E374098A64EDQ35116174-A0CAD435-F5AE-4C42-807A-4BFD7665741DQ35139440-AF0D75CC-CBF0-452F-8782-9AAC2428636EQ35139714-15303525-4893-4567-999E-D66B14F7C726Q35144570-65C99ED9-F517-42BD-84E8-27832CF26ABBQ35165008-BB3308DF-CD95-4D7A-9F9B-1C826A65057AQ35203120-C1221DB9-594F-4508-AD5E-77254E900307Q35208845-6843A0BE-0A8F-41A5-A2DB-13987692E17AQ35297743-1F930CDD-168B-4D17-A7C5-6484E1236639Q35482558-8DE3CD6E-E3D5-431D-8F2A-91D60B093B36Q35570710-5B5A37BC-8912-4D1F-B575-A85B3E78F039Q35607909-173DD1A6-0413-41F9-9D70-4ED7151B25E5Q35617499-012057F4-D338-4078-852B-02151C94E8FCQ35676151-F6AFA29C-4F7B-452C-BFC7-CCABBE67B4C2Q35689071-C1A7EDD4-C8AD-481E-A0A4-29BE083BFC94Q35745755-EC4696E1-948F-4C33-A64D-1F6B58FB9C0F
P2860
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@en
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@nl
type
label
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@en
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@nl
prefLabel
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@en
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@nl
P2093
P2860
P356
P1476
Molecular mechanisms disruptin ...... clinical isolates from the UK.
@en
P2093
David M Livermore
Matthew J Ellington
Michel Doumith
P2860
P304
P356
10.1093/JAC/DKP029
P407
P577
2009-02-20T00:00:00Z